GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
D

Diamyd Medical DMYD B.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

0.98

+0.61%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 130,000

FY2016FY2025

Net income

−SEK 169.8m

FY2016FY2025

Free cash flow

−SEK 179.7m

FY2016FY2025

Shareholders' equity

SEK 280.0m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSEK 130,000SEK 130,000SEK 546,000SEK 454,000SEK 253,000SEK 341,000SEK 1.6mSEK 726,000SEK 922,000SEK 757,000
Research and developmentSEK 119.5mSEK 96.5mSEK 69.9mSEK 75.6mSEK 56.9mSEK 13.8mSEK 22.4mSEK 29.1mSEK 12.9mSEK 6.2m
Operating income−SEK 183.2m−SEK 146.6m−SEK 120.8m−SEK 118.2m−SEK 85.9mSEK 9.7m−SEK 36.6m−SEK 44.0m−SEK 25.5m−SEK 32.1m
Net income−SEK 169.8m−SEK 151.8m−SEK 116.1m−SEK 103.5mSEK 60.0mSEK 9.7m−SEK 36.7m−SEK 44.0m−SEK 25.6m−SEK 32.0m
Diluted earnings per share-1.23-1.48-1.33-1.310.830.14-0.53-0.78-0.45-0.93

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 352.6mSEK 217.0mSEK 205.8mSEK 236.5mSEK 201.4mSEK 89.8mSEK 74.2mSEK 55.0mSEK 98.6mSEK 37.8m
Cash and short-term investmentsSEK 277.2mSEK 132.4mSEK 127.5mSEK 159.7mSEK 139.4mSEK 68.4mSEK 56.7mSEK 44.1mSEK 85.7mSEK 31.4m
Total liabilitiesSEK 72.6mSEK 71.1mSEK 36.4mSEK 22.1mSEK 12.2mSEK 17.3mSEK 11.4mSEK 12.0mSEK 12.0mSEK 8.5m
DebtSEK 45.0mSEK 30.7mSEK 15.9mSEK 57,000——————
Shareholders' equitySEK 280.0mSEK 145.9mSEK 169.4mSEK 214.4mSEK 189.3mSEK 72.5mSEK 62.8mSEK 43.0mSEK 86.7mSEK 29.3m
Shares outstanding137m102m87m79m72m71m69m56m56m34m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−SEK 169.7m−SEK 129.2m−SEK 111.0m−SEK 93.2m−SEK 109.5mSEK 16.9m−SEK 39.2m−SEK 41.6m−SEK 25.8m−SEK 17.8m
Capital spending−SEK 10.0m−SEK 8.0m−SEK 11.4m−SEK 34.7m−SEK 4.2m−SEK 2.0m−SEK 2.0m−SEK 347,000−SEK 347,000—
Free cash flow−SEK 179.7m−SEK 137.2m−SEK 122.4m−SEK 127.9m−SEK 113.7mSEK 14.9m−SEK 41.2m−SEK 41.9m−SEK 26.2m−SEK 17.8m

Latest quarters

By quarter end

Aug 2026May 2026Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024
RevenueSEK 65,000SEK 69,000SEK 99,000SEK 244,000SEK 18,000−SEK 1,000SEK 86,000SEK 25,000
Operating income−SEK 16.5m−SEK 127.2m−SEK 65.9m−SEK 49.8m−SEK 46.5m−SEK 48.1m−SEK 45.7m−SEK 42.9m
Net income−SEK 16.8m−SEK 127.1m−SEK 62.9m−SEK 48.8m−SEK 44.9m−SEK 43.9m−SEK 44.9m−SEK 36.2m
Diluted earnings per share-0.11-0.82-0.41-0.36-0.33-0.32-0.33-0.35
Cash from operations—−SEK 71.0m−SEK 39.0m−SEK 43.0m−SEK 35.0m−SEK 43.0m−SEK 48.0m−SEK 41.0m
Capital spending————−SEK 2.0m−SEK 4.0m—−SEK 2.0m
Free cash flow————−SEK 37.0m−SEK 47.0m—−SEK 43.0m
Total assets—SEK 406.6mSEK 253.6mSEK 302.5mSEK 352.6mSEK 400.1mSEK 180.9mSEK 222.9m
Cash and short-term investments—SEK 346.1mSEK 190.7mSEK 233.2mSEK 277.2mSEK 319.3mSEK 103.8mSEK 152.9m
Debt——SEK 42.9mSEK 45.0mSEK 45.0mSEK 45.5mSEK 43.0mSEK 43.6m
Shareholders' equity—SEK 259.4mSEK 169.8mSEK 231.6mSEK 280.0mSEK 324.7mSEK 111.5mSEK 156.1m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-34.1%-17.5%-12.8%
Operating income15.7%—23.9%
Net income17.9%—23.0%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-126847.3%-45141.7%-34785.7%-12692.1%
Net margin-123702.7%-42953.7%-25429.4%-9954.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-9.1-7.0-3.1-6.311.0139.1-29.0-5.5-4.6-3.8
Price to sales———————330.9127.6161.5

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.